thyroxine has been researched along with Bowel Diseases, Inflammatory in 6 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoporosis is a skeletal disorder characterized by decreased mass and compromised bone strength predisposing to an increased risk of fractures." | 2.52 | Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. ( Canalis, E; Mirza, F, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bertani, L | 3 |
| Tricò, D | 3 |
| Pugliese, D | 2 |
| Privitera, G | 1 |
| Linsalata, G | 1 |
| Zanzi, F | 1 |
| Gloria Mumolo, M | 1 |
| Barberio, B | 1 |
| Monzani, F | 1 |
| Marchi, S | 1 |
| Guidi, L | 1 |
| Blandizzi, C | 2 |
| Armuzzi, A | 1 |
| Costa, F | 2 |
| Carbery, I | 1 |
| Selinger, CP | 1 |
| Paschou, SA | 1 |
| Palioura, E | 1 |
| Kothonas, F | 1 |
| Myroforidis, A | 1 |
| Loi, V | 1 |
| Poulou, A | 1 |
| Goumas, K | 1 |
| Effraimidis, G | 1 |
| Vryonidou, A | 1 |
| Mirza, F | 1 |
| Canalis, E | 1 |
1 review available for thyroxine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
Topics: Acromegaly; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autoimmune Diseases; Celiac Disea | 2015 |
5 other studies available for thyroxine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue.
Topics: Biomarkers; Humans; Inflammatory Bowel Diseases; Thyroxine; Triiodothyronine | 2022 |
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
Topics: Aged; Biological Therapy; Humans; Inflammatory Bowel Diseases; Middle Aged; Thyroxine; Treatment Out | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal A | 2018 |